Telomir Pharmaceuticals (Telomir Pharmaceuticals) Interest Expense : $-5.98 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Telomir Pharmaceuticals's interest expense for the three months ended in Mar. 2024 was $ -4.34 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-5.98 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Telomir Pharmaceuticals's Operating Income for the three months ended in Mar. 2024 was $ -1.92 Mil. Telomir Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was $ -4.34 Mil. Telomir Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Telomir Pharmaceuticals Interest Expense Historical Data

The historical data trend for Telomir Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Interest Expense Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

-1.64

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial				-	-0.12	-0.76	-0.76	-4.34

Telomir Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.98 Mil.

Telomir Pharmaceuticals (NAS:TELO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Telomir Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was $-4.34 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-1.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

Telomir Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Telomir Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024